AstraZeneca scraps plan to expand vaccine plant in the UK

The government may have strong arguments for denying AstraZeneca's demands, but they may be harder to sustain given the sector - high-growth life sciences; the company - Britain's largest by market ...
AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...
Telegraph investigation has found ‘critical’ information was missing from early warnings about vaccine’s side effects ...
The move comes as the company faces ‘several challenges’ around the launching of medicines and timed out patents ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...